Despite these findings, the exact mechanisms through which CD40LG influences tumor development and immune interactions in NSCLC remain to be fully elucidated, necessitating further experimental studies to explore the potential therapeutic implications of targeting CD40LG in cancer. This evidence concerns the gene CD40LG and non-small cell lung carcinoma.